TABLE 1

Effect of P. ginseng and P. quinquefolius extracts on CYP2B1 and CYP3A23 mRNA expression in primary cultures of rat hepatocytes

Primary cultures of rat hepatocytes were treated for 48 h with P. ginseng extract (0.1-1000 μg/ml), P. quinquefolius extract (0.1-1000 μg/ml), or culture medium (vehicle control). Cultured hepatocytes were also treated with PB (100 μM; as a positive control for CYP2B1), DEX (10 μM; as a positive control for CYP3A23), or 0.1% DMSO (vehicle control). Total RNA was isolated and reverse transcribed. CYP2B1 and CYP3A23 cDNAs were amplified in duplicate by real-time PCR using gene-specific primers. Data are expressed as the mean (± S.E.M.) fold-increase in mRNA expression (relative to the respective vehicle controls) in hepatocytes isolated from three individual rats.


Treatment

CYP2B1 mRNA

CYP3A23 mRNA
fold-increase relative to control
P. ginseng Extract (μg/ml)
0.1 0.78 ± 0.05 0.98 ± 0.14
1 0.86 ± 0.08 0.92 ± 0.02
10 0.95 ± 0.23 0.96 ± 0.21
100 0.93 ± 0.27 0.79 ± 0.01
1000 0.51 ± 0.25 0.31 ± 0.10*
P. quinquefolius Extract (μg/ml)
0.1 0.84 ± 0.11 0.78 ± 0.01
1 0.78 ± 0.07 0.60 ± 0.08
10 0.88 ± 0.14 0.72 ± 0.06
100 1.16 ± 0.26 1.00 ± 0.20
1000 0.47 ± 0.11* 0.87 ± 0.14
PB (100 μM) 49 ± 22* not determined
DEX (10 μM)
not determined
41 ± 2*
  • * Significantly different from the corresponding vehicle-treated control group (p < 0.05).